[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prostate-Specific Antigen (PSA) Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030

June 2024 | 104 pages | ID: GFEFA073D56BEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Prostate-Specific Antigen (PSA) Test market size was valued at USD 525.8 million in 2023 and is forecast to a readjusted size of USD 638.5 million by 2030 with a CAGR of 2.8% during review period.

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

The Global Info Research report includes an overview of the development of the Prostate-Specific Antigen (PSA) Test industry chain, the market status of Screening (CLIA, ELISA), Post-treatment Monitoring (CLIA, ELISA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostate-Specific Antigen (PSA) Test.

Regionally, the report analyzes the Prostate-Specific Antigen (PSA) Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostate-Specific Antigen (PSA) Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Prostate-Specific Antigen (PSA) Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostate-Specific Antigen (PSA) Test industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CLIA, ELISA).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostate-Specific Antigen (PSA) Test market.

Regional Analysis: The report involves examining the Prostate-Specific Antigen (PSA) Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostate-Specific Antigen (PSA) Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Prostate-Specific Antigen (PSA) Test:

Company Analysis: Report covers individual Prostate-Specific Antigen (PSA) Test players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostate-Specific Antigen (PSA) Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Screening, Post-treatment Monitoring).

Technology Analysis: Report covers specific technologies relevant to Prostate-Specific Antigen (PSA) Test. It assesses the current state, advancements, and potential future developments in Prostate-Specific Antigen (PSA) Test areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostate-Specific Antigen (PSA) Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Prostate-Specific Antigen (PSA) Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • CLIA
  • ELISA
  • Other
Market segment by Application
  • Screening
  • Post-treatment Monitoring
  • Other
Market segment by players, this report covers
  • Abbott
  • Siemens Healthcare
  • DiaSorin
  • Roche
  • Beckman Coulter
  • PerkinElmer
  • Tosoh
  • Ortho Clinical
  • Fujirebio
  • Mediwatch (LABORIE)
  • BodiTech
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Prostate-Specific Antigen (PSA) Test product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Prostate-Specific Antigen (PSA) Test, with revenue, gross margin and global market share of Prostate-Specific Antigen (PSA) Test from 2019 to 2024.

Chapter 3, the Prostate-Specific Antigen (PSA) Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Prostate-Specific Antigen (PSA) Test market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate-Specific Antigen (PSA) Test.

Chapter 13, to describe Prostate-Specific Antigen (PSA) Test research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate-Specific Antigen (PSA) Test
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prostate-Specific Antigen (PSA) Test by Type
  1.3.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type in 2023
  1.3.3 CLIA
  1.3.4 ELISA
  1.3.5 Other
1.4 Global Prostate-Specific Antigen (PSA) Test Market by Application
  1.4.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Screening
  1.4.3 Post-treatment Monitoring
  1.4.4 Other
1.5 Global Prostate-Specific Antigen (PSA) Test Market Size & Forecast
1.6 Global Prostate-Specific Antigen (PSA) Test Market Size and Forecast by Region
  1.6.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Region, (2019-2030)
  1.6.3 North America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
  1.6.4 Europe Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
  1.6.6 South America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 Abbott
  2.1.1 Abbott Details
  2.1.2 Abbott Major Business
  2.1.3 Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Abbott Recent Developments and Future Plans
2.2 Siemens Healthcare
  2.2.1 Siemens Healthcare Details
  2.2.2 Siemens Healthcare Major Business
  2.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Siemens Healthcare Recent Developments and Future Plans
2.3 DiaSorin
  2.3.1 DiaSorin Details
  2.3.2 DiaSorin Major Business
  2.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 DiaSorin Recent Developments and Future Plans
2.4 Roche
  2.4.1 Roche Details
  2.4.2 Roche Major Business
  2.4.3 Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Roche Recent Developments and Future Plans
2.5 Beckman Coulter
  2.5.1 Beckman Coulter Details
  2.5.2 Beckman Coulter Major Business
  2.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Beckman Coulter Recent Developments and Future Plans
2.6 PerkinElmer
  2.6.1 PerkinElmer Details
  2.6.2 PerkinElmer Major Business
  2.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 PerkinElmer Recent Developments and Future Plans
2.7 Tosoh
  2.7.1 Tosoh Details
  2.7.2 Tosoh Major Business
  2.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Tosoh Recent Developments and Future Plans
2.8 Ortho Clinical
  2.8.1 Ortho Clinical Details
  2.8.2 Ortho Clinical Major Business
  2.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Ortho Clinical Recent Developments and Future Plans
2.9 Fujirebio
  2.9.1 Fujirebio Details
  2.9.2 Fujirebio Major Business
  2.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Fujirebio Recent Developments and Future Plans
2.10 Mediwatch (LABORIE)
  2.10.1 Mediwatch (LABORIE) Details
  2.10.2 Mediwatch (LABORIE) Major Business
  2.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Mediwatch (LABORIE) Recent Developments and Future Plans
2.11 BodiTech
  2.11.1 BodiTech Details
  2.11.2 BodiTech Major Business
  2.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
  2.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 BodiTech Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Prostate-Specific Antigen (PSA) Test by Company Revenue
  3.2.2 Top 3 Prostate-Specific Antigen (PSA) Test Players Market Share in 2023
  3.2.3 Top 6 Prostate-Specific Antigen (PSA) Test Players Market Share in 2023
3.3 Prostate-Specific Antigen (PSA) Test Market: Overall Company Footprint Analysis
  3.3.1 Prostate-Specific Antigen (PSA) Test Market: Region Footprint
  3.3.2 Prostate-Specific Antigen (PSA) Test Market: Company Product Type Footprint
  3.3.3 Prostate-Specific Antigen (PSA) Test Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Prostate-Specific Antigen (PSA) Test Consumption Value and Market Share by Type (2019-2024)
4.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2024)
5.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Application (2025-2030)

6 NORTH AMERICA

6.1 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
6.2 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country
  6.3.1 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
  6.3.2 United States Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  6.3.3 Canada Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  6.3.4 Mexico Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
7.2 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country
  7.3.1 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
  7.3.2 Germany Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  7.3.3 France Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  7.3.5 Russia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  7.3.6 Italy Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region
  8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2030)
  8.3.2 China Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  8.3.3 Japan Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  8.3.4 South Korea Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  8.3.5 India Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  8.3.7 Australia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
9.2 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
9.3 South America Prostate-Specific Antigen (PSA) Test Market Size by Country
  9.3.1 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
  9.3.2 Brazil Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  9.3.3 Argentina Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country
  10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
  10.3.2 Turkey Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
  10.3.4 UAE Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Prostate-Specific Antigen (PSA) Test Market Drivers
11.2 Prostate-Specific Antigen (PSA) Test Market Restraints
11.3 Prostate-Specific Antigen (PSA) Test Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Prostate-Specific Antigen (PSA) Test Industry Chain
12.2 Prostate-Specific Antigen (PSA) Test Upstream Analysis
12.3 Prostate-Specific Antigen (PSA) Test Midstream Analysis
12.4 Prostate-Specific Antigen (PSA) Test Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 8. Abbott Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 11. Siemens Healthcare Major Business
Table 12. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 13. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Siemens Healthcare Recent Developments and Future Plans
Table 15. DiaSorin Company Information, Head Office, and Major Competitors
Table 16. DiaSorin Major Business
Table 17. DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 18. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. DiaSorin Recent Developments and Future Plans
Table 20. Roche Company Information, Head Office, and Major Competitors
Table 21. Roche Major Business
Table 22. Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 23. Roche Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Roche Recent Developments and Future Plans
Table 25. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 26. Beckman Coulter Major Business
Table 27. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 28. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Beckman Coulter Recent Developments and Future Plans
Table 30. PerkinElmer Company Information, Head Office, and Major Competitors
Table 31. PerkinElmer Major Business
Table 32. PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 33. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. PerkinElmer Recent Developments and Future Plans
Table 35. Tosoh Company Information, Head Office, and Major Competitors
Table 36. Tosoh Major Business
Table 37. Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 38. Tosoh Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Tosoh Recent Developments and Future Plans
Table 40. Ortho Clinical Company Information, Head Office, and Major Competitors
Table 41. Ortho Clinical Major Business
Table 42. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 43. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ortho Clinical Recent Developments and Future Plans
Table 45. Fujirebio Company Information, Head Office, and Major Competitors
Table 46. Fujirebio Major Business
Table 47. Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 48. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Fujirebio Recent Developments and Future Plans
Table 50. Mediwatch (LABORIE) Company Information, Head Office, and Major Competitors
Table 51. Mediwatch (LABORIE) Major Business
Table 52. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 53. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Mediwatch (LABORIE) Recent Developments and Future Plans
Table 55. BodiTech Company Information, Head Office, and Major Competitors
Table 56. BodiTech Major Business
Table 57. BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 58. BodiTech Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. BodiTech Recent Developments and Future Plans
Table 60. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Players (2019-2024)
Table 61. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players (2019-2024)
Table 62. Breakdown of Prostate-Specific Antigen (PSA) Test by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Prostate-Specific Antigen (PSA) Test, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Prostate-Specific Antigen (PSA) Test Players
Table 65. Prostate-Specific Antigen (PSA) Test Market: Company Product Type Footprint
Table 66. Prostate-Specific Antigen (PSA) Test Market: Company Product Application Footprint
Table 67. Prostate-Specific Antigen (PSA) Test New Market Entrants and Barriers to Market Entry
Table 68. Prostate-Specific Antigen (PSA) Test Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Prostate-Specific Antigen (PSA) Test Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Type (2019-2024)
Table 71. Global Prostate-Specific Antigen (PSA) Test Consumption Value Forecast by Type (2025-2030)
Table 72. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024)
Table 73. Global Prostate-Specific Antigen (PSA) Test Consumption Value Forecast by Application (2025-2030)
Table 74. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Prostate-Specific Antigen (PSA) Test Raw Material
Table 105. Key Suppliers of Prostate-Specific Antigen (PSA) Test Raw Materials

LIST OF FIGURES

Figure 1. Prostate-Specific Antigen (PSA) Test Picture
Figure 2. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type in 2023
Figure 4. CLIA
Figure 5. ELISA
Figure 6. Other
Figure 7. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application in 2023
Figure 9. Screening Picture
Figure 10. Post-treatment Monitoring Picture
Figure 11. Other Picture
Figure 12. Global Prostate-Specific Antigen (PSA) Test Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Prostate-Specific Antigen (PSA) Test Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Prostate-Specific Antigen (PSA) Test Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region in 2023
Figure 17. North America Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players in 2023
Figure 23. Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Prostate-Specific Antigen (PSA) Test Market Share in 2023
Figure 25. Global Top 6 Players Prostate-Specific Antigen (PSA) Test Market Share in 2023
Figure 26. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Type (2019-2024)
Figure 27. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Type (2025-2030)
Figure 28. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Application (2019-2024)
Figure 29. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Application (2025-2030)
Figure 30. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 40. France Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region (2019-2030)
Figure 47. China Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 50. India Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
Figure 64. Prostate-Specific Antigen (PSA) Test Market Drivers
Figure 65. Prostate-Specific Antigen (PSA) Test Market Restraints
Figure 66. Prostate-Specific Antigen (PSA) Test Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Prostate-Specific Antigen (PSA) Test in 2023
Figure 69. Manufacturing Process Analysis of Prostate-Specific Antigen (PSA) Test
Figure 70. Prostate-Specific Antigen (PSA) Test Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source


More Publications